Panelists at the CED March Biotech Forum panel will discuss the advantages and challenges of creative approaches in clinical trial design.
On the “Effective Clinical Trial Design and Lessons Learned” panel, speakers will highlight lessons learned from “failed” trials, and they will also provide tips for ensuring that data analysis efforts provide meaningful insights into further development of the product candidate.
Speakers include moderator Mary Bennett, senior vice president of operations and communications for Inspire Pharmaceuticals; Lisa Beth Ferstenberg, president and chief executive officer of Cellective Therapeutics; Charlie Lineberry, CEO of Lineberry Research Associates; and Amy Schaberg, VP of clinical research at Inspire.
The CED’s Biotech Forum will be held on March 8 from 5-8 PM at the N.C. Biotechnology Center on Alexander Drive in RTP. The cost for CED and NCBio members is $20 and $35 for others. The price increases $5 on-site.
CED: www.cednc.org
